Investigator Profile: Jonathan Sham, MD, MBEE
Pancreas surgery gives patients the best chance for a potential cure, but the procedure doesn't come without risks. The most significant complication after pancreatic surgery is a postoperative pancreatic fistula, which occurs in up to 50% of cases. Many surgical and pharmacologic interventions have been trialed to reduce the rate of pancreatic fistulas, unfortunately, none have proven effective. Our lab is working on a different approach, using advanced biotechnology to mitigate and prevent pancreas leaks. Our lab is creating novel, biocompatible, biodegradable, drug-eluting polymers to seal pancreatic leakage and decrease pancreatic fluid secretion to improve patient outcomes. While this important work has just begun, these efforts are showing great promise and we hope to rapidly bring our technology from bench to bedside.